This report focuses on clinical trials in China. It identifies market dynamics, key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in China. The market analysis report “Clinical trials in China” will maximize your savings and avoid costly mistakes.
This report provides:
1. A better comprehension of the Chinese clinical trial market:
- A global economic & demographic Chinese market review - A draw up of an up-to-date regulatory and legislation situation including all the major reforms related to clinical trials - A comprehensive analysis of the market drivers and barriers - The main actors of the market - An exhaustive list and analysis of the main CROs including contact database - The clinical study design and planning in China - An overview of the trends, opportunities and challenges for the future - Strategic recommendations
2. Answers to your business interrogations:
- Why has China become a key destination for clinical trials? - What are the major drivers of this geographic clinical trials decentralization? - What are the remaining challenges for multinational clinical trials? - What is the process of clinical trials for imported drugs? - What are the major types of clinical trials conducted in China? - How does SFDA reform the healthcare environment in order to be in accordance with Western countries regulatory environment?
3. An exhaustive synthesis of the main CROs located in China:
- Get an identification sheet per CRO - Know about their major activities - Have an exhaustive list of Multinational & National CROs settled in China - Have an overview of their pharmaceutical customers
Product samples
A sample for this product is available. Please Login/Register to download this sample.
